Back
13
Day Range
$1.90
$2.21
52-Week Range
$1.90
$2.21
Volume
1,510
50D / 200D Avg
$1.90
/
$1.90
Prev Close
$1.90
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.2 | 10.4 |
| P/B | 0.1 | 1.2 |
| ROE % | 24.1 | 12.3 |
| Net Margin % | 11.5 | 5.3 |
| Rev Growth 5Y % | -3.4 | 5.6 |
| D/E | 0.5 | 0.6 |
Key Takeaways
Revenue declined -3.38% annually over 5 years
ROE of 24.11% indicates high profitability
Generating 3.94B in free cash flow
P/E of 0.21 — trading at a low valuation
Cash machine — converts 97.19% of earnings into free cash flow
Capital efficient — spends only 2.44% of revenue on capex
Growth
Revenue Growth (5Y)
-3.38%
Revenue (1Y)-1.58%
Earnings (1Y)N/A
FCF Growth (3Y)68.62%
Quality
Return on Equity
24.11%
ROIC2.78%
Net Margin11.53%
Op. Margin2.78%
Safety
Debt / Equity
0.51
Current Ratio1.04
Interest Coverage0.72
Valuation
P/E Ratio
0.21
P/B Ratio0.05
EV/EBITDA6.83
Dividend Yield0.13%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.58% | Revenue Growth (3Y) | -4.83% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 134.66% |
| Revenue Growth (5Y) | -3.38% | Earnings Growth (5Y) | 10.57% |
| Profitability | |||
| Revenue (TTM) | 35.13B | Net Income (TTM) | 4.05B |
| ROE | 24.11% | ROA | 10.11% |
| Gross Margin | 18.21% | Operating Margin | 2.78% |
| Net Margin | 11.53% | Free Cash Flow (TTM) | 3.94B |
| ROIC | 2.78% | FCF Growth (3Y) | 68.62% |
| Safety | |||
| Debt / Equity | 0.51 | Current Ratio | 1.04 |
| Interest Coverage | 0.72 | Dividend Yield | 0.13% |
| Valuation | |||
| P/E Ratio | 0.21 | P/B Ratio | 0.05 |
| P/S Ratio | 0.02 | PEG Ratio | -0.01 |
| EV/EBITDA | 6.83 | Dividend Yield | 0.13% |
| Market Cap | 867.51M | Enterprise Value | 6.68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 35.13B | 35.69B | 38.78B | 44.70B | 40.31B |
| Net Income | 4.05B | -1.35B | 735.52M | 1.87B | 2.71B |
| EPS (Diluted) | 9.36 | -3.09 | 1.61 | 4.27 | 6.18 |
| Gross Profit | 6.40B | 4.92B | 5.43B | 5.73B | 6.32B |
| Operating Income | 977.11M | 1.05B | 1.44B | 2.87B | 4.51B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40.06B | 46.01B | 43.99B | 49.36B | 50.32B |
| Total Liabilities | 22.64B | 29.82B | 27.49B | 32.22B | 34.09B |
| Shareholders' Equity | 17.41B | 16.19B | 16.49B | 17.14B | 16.23B |
| Total Debt | 8.94B | 13.98B | 13.01B | 15.29B | 16.55B |
| Cash & Equivalents | 3.13B | 2.22B | 1.83B | 2.33B | 4.38B |
| Current Assets | 13.82B | 17.90B | 15.30B | 17.95B | 18.61B |
| Current Liabilities | 13.29B | 14.44B | 13.01B | 15.93B | 16.69B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#497 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026